Amnon Eylath
U.S. Quality Lead
- Oculis
Amnon Eylath is a global Quality leader, consultant, and auditor with a proven track record of shaping organizational quality culture, influencing global policy, and driving innovation and continuous improvement at large companies including Amgen, Eli Lilly, and Sanofi Genzyme, as well as multiple start-up companies in the United States and internationally.
He champions the application of science- and compliance-based thinking to the design, execution, and risk mitigation of GXP quality systems and operational activities. Amnon is a GXP Quality and Compliance innovator and influencer with experience across the complete lifecycle of small molecule, ATMP, and biological drug development, from R&D, product and clinical development, and regulatory submissions through US, EU, and MHRA commercial product approvals.
As Founder of Broad Spectrum GXPâ„¢, Amnon provides strategic consulting, operational services, auditing, and interim leadership to help organizations close gaps, mitigate risk, achieve inspection readiness, and advance operational excellence. He is committed to developing high-performing teams and building sustainable quality systems that support both compliance and business performance.